CIS Life Sciences

The Life Sciences sector continues to grow at a rate exceeding GDP whilst operating in an environment that becomes ever more complicated. Key issues facing pharmaceutical, biotech and medical device organizations include:

1. Demanding clinical and regulatory standards
2. Industry consolidation
3. Diminishing R&D pipelines
4. Reduced patent exclusivity
5. Increased generic competition
6. Increased in-licensing activity
7. A maturing biotech sector
8. Increased importance of health outcomes research
9. Reduction in traditional sales model effectiveness
10. Pricing & Reimbursement pressures
11. Productivity and cost pressures
12. Emergence in importance of developing markets
    
    

A key requirement for a company to successfully support strategic and tactical decision making revolves around the availability of detailed intelligence on the structures, activities, resources, strategies and performance of competitors. Life Sciences companies require intelligence to structure development pipelines, commercialize products successfully, improve productivity and enhance profits through brand dominance in selected markets.